Remove 2018 Remove Clinic Remove Education Remove Specialization
article thumbnail

Internal Medicine 2018 Categorical Candidate Interviews

Louisville Lectures

We are excited to help expand the FOAMed movement into internal medicine where so much work has been done by various medical education programs. "I These will focus on delivering just-in-time algorithms, practical clinical knowledge and board tips on high-yield topics. Visit here. Visit here.

article thumbnail

Episode 134: WDx Episode #4 – The CPSolvers discuss gender biases and stereotypes with special guest Dr. Julie Ann Sosa

The Clinical Problem Solvers

Dr Sosa came to UCSF in 2018 from Duke. Her clinical interest is in endocrine surgery, with a focus in thyroid cancer. Lee Institute for Health Policy Studies. She has authored or edited 7 books. Braverman Distinguished Lectureship Award from the ATA in 2017. Dr Sosa was born in Montreal and raised in upstate New York.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Nwamaka Eneanya and Jennifer Tsai to discuss the limitations and harms of race-based medicine in clinical practice. Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality.

Clinic 52
article thumbnail

Episode 262: Anti-Racism in Medicine Series – Episode 18 – Remedying Health Inequities Driven by the Carceral System

The Clinical Problem Solvers

Our guests remind us to think critically about our role in the carceral system and in imposing systems of control and punishment within clinical settings. Providing communities with the resources they need to survive, such as educational opportunities, jobs, and quality healthcare, will eliminate the need for incarceration.

article thumbnail

The Future Of Vision And Eye Care

The Medical Futurist

Their research showed promising results for lab rats, and they plan to carry out the first human trials in the second half of 2017 and gather preliminary results during 2018. Experts even say the eye is an ideal place to start for the first clinical use of CRISPR. The Stanford Artificial Retina Project shows great promises.

Diabetes 105
article thumbnail

Mastering Responses to FDA 510(k) AI Letters: A Strategic Approach

FDA Law

Understanding the Traditional 510(k) Review Timeline There are three types of Premarket Notification 510(k)s: Traditional , Special , and Abbreviated. Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 Average Number of Industry Days to MDUFA IV Decision 54.69

article thumbnail

Rethinking Opioid Conversions: Mary Lynn McPherson and Drew Rosielle

GeriPal

It depends on the clinical situation. But we still, regardless of how you do this calculation have to temper it with clinical judgment. Mary Lynn: I’m willing to bet that you temper that calculation with your clinical judgment though. I think we are obliged, and speaking as a clinician educator here. Eric: Yeah.

IT 139